Other side effects are rare but may include: constipation, stomach pain, headache, fatigue, indigestion, dizziness, abdominal distension, belching, gas build-up, and low blood sugar in patients with Type 2 diabetes
The Phase II trials of Retatrutide have generated excitement by showcasing weight loss outcomes of up to 24% over an 11-month period
Our analysis indicates that between 20 and 30 percent of annual patients stop using the drugs, particularly those focused on weight loss, and these patients regain about two-thirds of the weight they lost
anesthetic factors such as light anesthesia, supraglottic airways, positive pressure ventilation, duration of surgery greater than two hours, or difficult airway
Insurance coverage for Retatrutide in Chula Vista is uncertain until FDA approval is secured
Referred to as ileus, the condition occurs when the muscles are unable to move food through the intestines, resulting in a blockage